Likewise, the 3- and 5-year cumulative survival rates for ESCC patients with high WNT5A expression (17.6 and 14.9%, respectively) were much lower than those for patients with low WNT5A expression (70.4 and 62.0%, respectively) (Supplementary Table 1). Here, WNT5A is linked to esophageal squamous cell carcinoma.